- Cardiac ardiac valves, which regulate blood flow through the heart’s chambers, are becoming increasingly crucial in cardiovascular treatment due to their role in addressing valve dysfunctions such as stenosis and regurgitation, with both mechanical and tissue valves used in surgical and transcatheter procedures across global healthcare systems
- The rising demand for cardiac valve interventions is primarily driven by the increasing prevalence of heart valve diseases, aging populations, and growing awareness of minimally invasive procedures that reduce recovery time and surgical risks
- North America dominated the cardiac valve market with the largest revenue share of 39.2% in 2024, attributed to advanced healthcare infrastructure, a high burden of cardiovascular diseases, and the early adoption of next-generation valve technologies, especially in the United States, where favorable reimbursement policies and high surgical volumes further support market growth
- Asia-Pacific is expected to be the fastest growing region in the cardiac valve market during the forecast period due to expanding healthcare access, increasing healthcare expenditure, and rising demand for valve repair and replacement procedures
- Transcatheter heart valve segment dominated the cardiac valve market with a market share of 42.1% in 2024, driven by its rapid adoption as a less invasive alternative to open-heart surgery, particularly for high-risk and elderly patients
